PD

Paul Da Silva Jardine

Venture Partner at Apple Tree Partners

Guilford, Connecticut

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Pharmaceutical Industry
Life Sciences
Biotechnology
Biomarkers
Clinical Trials
Cardiovascular Disease
Clinical Development
Chemistry
Drug Development
Clinical Research
Drug Discovery
Oncology

Education

Lists including Paul

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Red Queen Therapeutics

Series A

Total Funding: $55M

Deep Apple Therapeutics

Series A

Total Funding: $52M

Aethon Therapeutics

Series A

Total Funding: $30M

Work Experience

Apple Tree Partners

2021

  • Venture Partner

    2021

Staten Biotechnology

2015

  • Chief Scientific Officer

    2015

    Staten Biotechnology is a Precision Medicine Cardiovascular and Dyslipidemic company for targets with robust human genetics support

P
Pfizer

1989 - 2015

  • Vice President Cardiovascular and Metabolic Research

    2009 - 2015

  • Vice President, Head of Cardiovascular and Metabolic and Endocrine Diseases Chemistry

    2004 - 2009

  • Senior Director, Head of Obesity and Osteoporosis Chemistry CVMED

    2001 - 2004

  • Research Scientist to Director Chemistry

    1989 - 2001